tiprankstipranks
TrivarX Limited Awaits Key Study Results, Halts Trading
Company Announcements

TrivarX Limited Awaits Key Study Results, Halts Trading

TrivarX Limited (AU:TRI) has released an update.

Don't Miss our Black Friday Offers:

TrivarX Limited has requested an immediate trading halt pending an announcement about the results of their Phase 2 SAMDE study. The halt is in effect until the announcement is made or until market opening on Wednesday, 31 July 2024. The company has not provided further details regarding the reasons for the halt.

For further insights into AU:TRI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTrivarX Unveils Innovative Depression Screening Tool
TipRanks Australian Auto-Generated NewsdeskTrivarX Limited’s AI Algorithm Shows Promise in Depression Screening
TipRanks Australian Auto-Generated NewsdeskTrivarX Limited Plans New Securities Issue
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App